RedIF is the premier scientific network dedicated to promoting pharmacometrics throughout Ibero-America. Since our founding in 2017, we have brought together researchers, industry professionals, regulatory scientists, and clinicians to advance model-informed approaches in drug development and therapeutic optimization
The Ibero-American Pharmacometrics Network (RedIF) was established in 2017 as a collaborative initiative uniting research groups from across Latin America and Spain. Our network emerged from the recognition that pharmacometrics represents a transformational opportunity for developing countries to modernize pharmaceutical research, drug development, and clinical practice.
What is Pharmacometrics?
Pharmacometrics is the science of developing and applying mathematical and statistical methods to characterize, understand, and predict a drug’s exposure and response in different scenarios and populations. Through modeling and simulation (M&S), pharmacometrics enables data-driven decision-making throughout the drug development lifecycle and supports precision medicine in clinical settings.
Our Impact:
- Education: Workshops, congresses, and webinars delivered in Spanish and Portuguese to reduce language barriers
- Research: Multicenter collaborative studies advancing population pharmacometrics
- Capacity Building: Training the next generation of pharmacometricians in Latin America
- Regional Integration: Creating databases and harmonizing practices across Ibero-American countries
Global Recognition: Contributing to international discussions on barriers and opportunities for global pharmacometrics development
